[Use of repolarizing solutions in cardiological resuscitation. (Physiopathogenetic and electrophysiological considerations)].
D001145:Arrhythmias, Cardiac / Q000628:therapy; D001639:Bicarbonates / Q000627:therapeutic use; D004417:Dyspnea / Q000628:therapy; D005947:Glucose / Q000008:administration & dosage; D006333:Heart Failure / Q000517:prevention & control; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy*; D010138:Pacemaker, Artificial; D011732:Pyridoxal Phosphate / Q000008:administration & dosage; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000517:prevention & control; D012769:Shock / Q000517:prevention & control; D013835:Thiamine Pyrophosphate / Q000008:administration & dosage
D001639:Bicarbonates; D007328:Insulin; D011732:Pyridoxal Phosphate; D005947:Glucose; D013835:Thiamine Pyrophosphate; D006854:Hydrocortisone
L'impiego delle soluzioni ripolarizzanti nella rianimazione cardiologica. (Considerazioni fisiopatogenetiche ed elettrofisiologiche)